Pre-Existing Cellular Immunity to SARS-CoV-2 Through an Immunodominant Epitope
Katie E. Lineburg(QIMR Berghofer Medical Research Institute), Stéphanie Gras(La Trobe University), Corey Smith(QIMR Berghofer Medical Research Institute), Srividhya Swaminathan(The University of Queensland), Christopher Szeto(La Trobe University), Dhilshan Jayasinghe(La Trobe University), Alan Riboldi‐Tunnicliffe(Australian Nuclear Science and Technology Organisation), Lea Lekieffre(QIMR Berghofer Medical Research Institute), Kirsty R. Short(The University of Queensland), Emma J. Grant(La Trobe University), Zhen Tong(The University of Queensland), Weisan Chen(La Trobe University), Hannah Sloane(La Trobe University), Demetra S.M. Chatzileontiadou(La Trobe University), Rajiv Khanna(QIMR Berghofer Medical Research Institute), Hanim Halim(Monash University), Christian A. Lobos(La Trobe University), Andrea Nguyen(Monash Health), Archana Panikkar(QIMR Berghofer Medical Research Institute), Michelle A. Neller(QIMR Berghofer Medical Research Institute), Keng Yih Chew(Australian Research Council), Jyothy Raju(QIMR Berghofer Medical Research Institute), Pauline Crooks(QIMR Berghofer Medical Research Institute), Jacqueline M. Burrows(QIMR Berghofer Medical Research Institute), Sweera Rehan(QIMR Berghofer Medical Research Institute)
Cited by 2
Related Papers
Exosomes and their roles in immune regulation and cancer
|Seminars in Cell and Developmental Biology|2015|602
Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2
|The EMBO Journal|2020|499
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans
|Proceedings of the National Academy of Sciences|2004|440
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
|The Journal of Experimental Medicine|1992|391